Techonomy Bio 2015 Live Webcast

Techonomy Bio is a big-picture exploration of the transformative global social and economic benefits driven by the rapid advances being made in the biological and life sciences. Powered by IT developments and spurred on by new […]

Techonomy Bio is a big-picture exploration of the transformative global social and economic benefits driven by the rapid advances being made in the biological and life sciences. Powered by IT developments and spurred on by new collaborative and open-source thinking, these advances affect everything from manufacturing to medicine, food to fuel and business to buildings.

We explore the continued growth of digital health; how big data and the life sciences are combining to feed a growing global population; bio-fabrication and manufacturing; construction and architecture; longevity; ethics; business; industrial biosciences; privacy; policy; security; and more. We’ll also address what this all means for industries, for government and regulators, for investors and ultimately, for us.

At Techonomy Bio, we convened cross-sector leaders from biotech, IT, science, healthcare, pharma, agriculture, academia, finance and the synthetic bio community for an open and dynamic dialogue on the fast moving ideas, solutions and opportunities generated by the growing confluence of tech, bio and business.

Follow conversations about the event @Techonomy and #TechonomyBIO.

Webcast Schedule (All times PST ):

Wednesday, March 25:

8:30 – 8:40am Welcome

David Kirkpatrick, Chief Techonomist, Techonomy Media

8:40 – 9:30am You Say You Want a Revolution?

Tech is super-powering the life sciences. What sectors are best primed to be

disrupted by the burgeoning power of bio? Is the increasingly symbiotic

relationship between tech and bio the perpetual energy source that will drive

our future?

Speakers: Drew Endy, Associate Professor, Bioengineering, Stanford

University; President, The BioBricks Foundation

David Glazer, Director of Engineering, Google

Steve Jurvetson, Partner, DFJ

Chris Waller, Director, Scientific Modeling Platforms, Merck

Moderator: David Kirkpatrick, Chief Techonomist, Techonomy Media

9:30 – 9:40am Short Presentations

Targeting Pathogens to Treat the Brain

Casey Lynch, Co-founder and CEO, Cortexyme

Can You Teach an Old Doc New Tricks?

Greg Matthews, Founder & Managing Director, MDigitalLife

9:40 – 10:25am The Internet of (Bio)Things

We’re swimming in bio-data, from the human genome to the human

microbiome, the steps we take to the hours we sleep. Companies and

organizations provide tools that allow us to collect troves of data, the likes of

which we’ve never seen. What does that data teach us about ourselves? And

how do we use it to make smart decisions?

Speakers: Steve Axelrod, CEO, G-Tech Medical

Walter De Brouwer, Founder and CEO, Scanadu

Ajay Royyuru, Director, Computational Biology Center, IBM Research

Jennifer Tye, Vice President, Marketing and Partnerships, Glow

Moderator: Stephanie Lee, Senior Technology Reporter, BuzzFeed News

10:50 – 11:25am Bio At the Scale of Architecture 

New materials of construction are literally growing around us. From mycelium buildings to bio-masonry and cities that engage with the natural world around them, our structural, habitative interaction with the world around us is rapidly changing.

Speakers: Ginger Krieg Dosier, Founder and CEO, bioMASON

Danil Nagy, Associate Designer, The Living; Adjunct Assistant Professor of Architecture, Graduate School of Architecture, Planning and Preservation, Columbia University

Joe Tarantino, Fermentation Biologist, Ecovative

Moderator: Andrew Hessel, Distinguished Research Scientist, Autodesk

11:25 – 11:30am Short Presentation

Bio-origami: Building at the Nanoscale

Shawn Douglas, Principal Investigator, The Douglas Lab, UCSF

11:30 – 11:55am The Brain: Decoding the World’s Greatest Computer

What are we learning about the brain, thinking, and learning that’s already

being applied to people and machines?

Speakers: Terrence J. Sejnowski, Professor and Laboratory Head, Salk

Institute for Biological Studies

Richard Socher, Co-founder and CTO, MetaMind

Facilitator: Hemai Parthasarathy, Scientific Director, Breakout Labs

11:55am – 12:05pm Stem Cells: What We Know and What We Don’t

A presentation by Jeanne F. Loring, Professor and Director, Center for

Regenerative Medicine, Department of Chemical Physiology, The Scripps

Research Institute

12:05 – 12:45pm The Future of F & B

What happens when synthetic biology and biotech combine with food and

beverage science? Is growing things smarter the pathway to global sustenance?

Speakers: Jim Flatt, President, Genovia Bio, Synthetic Genomics

Andras Forgacs, Co-founder and Chief Executive, Modern Meadow

Randy Komisar, Partner, Kleiner Perkins Caufield and Byers

Reshma Shetty, Co-founder, Ginkgo Bioworks

Moderator: Paul Gurney, Associate Partner, McKinsey & Company

2:00 – 2:55pm Techonomy Labs (1 of 3) Who Owns Your Genetic Data?

If people increasingly think their personal digital data belongs to them, surely

personal genetic data must as well. How will that likelihood play out for

individuals, business, and governments?

Speakers: Linda Avey, Co-founder and CEO, We Are Curious; Co-founder,

23andMe

Henry T. Greely, Dean F. and Kate Edelman Johnson Professor of Law;

Director, Center for the Law and Biosciences, Stanford University

Elissa Levin, Head of Genomics and Integrative Health Solutions, Icahn

School of Medicine at Mount Sinai

Ajay Royyuru, Director, Computational Biology Center, IBM Research

Matt Wilsey, President, Grace Wilsey Foundation

Moderator: Meredith Salisbury, Editorial Director, Bioscribe

3:10 – 3:25pm Techonomy Lab Reports

Encapsulation and report back from the Techonomy Labs.

Presented by McKinsey & Company

3:25 – 4:10pm Sitting on a Can of Miracles

What has so many in the investment community so excited about the

remarkable pace of innovation they see today across the life sciences? What

would they love to see more of? And what are the areas that are most critical

to nurture in the long run?

Speakers: Ryan Bethencourt, Program Director and Venture Partner,

IndieBio

Amy DuRoss, Executive Director, New Business Creation, GE Ventures

Nancy Kelley, President, NJKA; Former Executive Director, New York

Genome Center

Gregory C. Simon, CEO, Poliwogg

Moderator: Samarth Kulkarni, Partner, McKinsey & Company

4:10 – 4:15pm Short Presentation

Growing Better Bones

Nina Tandon, CEO, EpiBone

4:15 – 4:40pm Evolving Ourselves

Juan Enriquez, Managing Director, Excel Venture Management; Co-author,

Evolving Ourselves, interviewed by David Kirkpatrick, Chief Techonomist,

Techonomy Media

For billions of years life on Earth was guided by Darwin’s two principles:

natural selection and random mutation. Over the past century humans have

become so powerful that they now select what lives and dies on half of the

planet, and they genetically engineer viruses, bacteria, plants, animals, and

even the next human generations. This un-natural state has doubled our life

spans but rapid evolution and selection can also have side effects like autism,

obesity and allergies. What are some of the consequences for health, ethics,

and business when we take control of our own evolution?

4:40 – 4:45pm Short Presentation

Quantifying Stress

Robert Goldberg, Founder, Neumitra

4:45 – 5:25pm Advances, Opportunities, and Challenges

How science is advancing human progress around the world, and where the

greatest challenges still remain.

Dr. Sue Desmond-Hellmann, CEO of the Bill & Melinda Gates Foundation,

interviewed by Marc Benioff, Chairman and CEO of Salesforce

Related Posts
See All

Business is the Battery of Society: Reflections On Innovation

Techonomy Bio is a big-picture exploration of the transformative global social and economic benefits driven by the rapid advances being made in the biological and life sciences. Powered by IT developments and spurred on by new...

My Epiphanies at a Climate Innovation Breakfast

Techonomy Bio is a big-picture exploration of the transformative global social and economic benefits driven by the rapid advances being made in the biological and life sciences. Powered by IT developments and spurred on by new...

It’s a Wrap: 9 Ways GE Put Words Into Action at COP27

Techonomy Bio is a big-picture exploration of the transformative global social and economic benefits driven by the rapid advances being made in the biological and life sciences. Powered by IT developments and spurred on by new...

A Highly Volatile World Demands New Solutions to Navigate Risk

Techonomy Bio is a big-picture exploration of the transformative global social and economic benefits driven by the rapid advances being made in the biological and life sciences. Powered by IT developments and spurred on by new...